This roundtable will explore how psychiatric pharmacists factor into MOUD treatment and the ways that they can support both the patients and the health care team. Three pharmacists will be present to provide a discussion and answer your questions.
At the conclusion of this activity participants should be able to:
- Understand the role psychiatric pharmacists can play in expanding access to quality care for those living with substance use disorders.
- Describe the benefits the psychiatric pharmacist brings to the healthcare team.
- Recognize successful models that incorporate the psychiatric pharmacist.
Target audience: Interprofessional teams, pharmacists and physicians
Credit designations available: AMA PRA Category 1 Credit™, Pharmacy CE Credit, Interprofessional Continuing Education (IPCE) Credit
In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit for this activity is designated for learners in the following ways:
Physicians
American Academy of Addiction Psychiatry designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy Designation Statement
This activity has been approved for 1 hours of pharmacy continuing education credit. The approval numbers issued are Universal Activity Numbers: JA4008192-0000-25-048-L99-P (pharmacy).
Other Health Professionals
Participants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credits™.
All Learners
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education credits for learning and change.
